Submit Manuscript  

Article Details


Suitable Signal Peptides for Secretory Production of Recombinant Granulocyte Colony Stimulating Factor in Escherichia coli

[ Vol. 14 , Issue. 4 ]

Author(s):

Sadra S. Tehrani, Golnaz Goodarzi, Mohsen Naghizadeh, Seyyed H. Khatami, Ahmad Movahedpour, Ali Abbasi, Zahra Shabaninejad, Nesa Khalaf, Mortaza Taheri-Anganeh* and Amir Savardashtaki*   Pages 269 - 282 ( 14 )

Abstract:


Background: Granulocyte colony-stimulating factor (G-CSF) expressed in engineered Escherichia coli (E. coli) as a recombinant protein is utilized as an adjunct to chemotherapy for improving neutropenia. Recombinant proteins overexpression may lead to the creation of inclusion bodies whose recovery is a tedious and costly process. To overcome the problem of inclusion bodies, secretory production might be used. To achieve a mature secretory protein product, suitable signal peptide (SP) selection is a vital step.

Objective: In the present study, we aimed at in silico evaluation of proper SPs for secretory production of recombinant G-CSF in E. coli.

Methods: Signal peptide website and UniProt were used to collect the SPs and G-CSF sequences. Then, SignalP were utilized in order to predict the SPs and location of their cleavage site. Physicochemical features and solubility were investigated by ProtParam and Protein-sol tools. Fusion proteins sub-cellular localization was predicted by ProtCompB.

Results: LPP, ELBP, TSH, HST3, ELBH, AIDA and PET were excluded according to SignalP. The highest aliphatic index belonged to OMPC, TORT and THIB and PPA. Also, the highest GRAVY belonged to OMPC, ELAP, TORT, BLAT, THIB, and PSPE. Furthermore, G-CSF fused with all SPs were predicted as soluble fusion proteins except three SPs. Finally, we found OMPT, OMPF, PHOE, LAMB, SAT, and OMPP can translocate G-CSF into extracellular space.

Conclusion: Six SPs were suitable for translocating G-CSF into the extracellular media. Although growing data indicate that the bioinformatics approaches can improve the precision and accuracy of studies, further experimental investigations and recent patents explaining several inventions associated to the clinical aspects of SPs for secretory production of recombinant GCSF in E. coli are required for final validation.

Keywords:

Bioinformatics, biopharmaceutical, filgrastim, recombinant protein, G-CSF, signal peptide.

Affiliation:

Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Department of Nanobiotechnology, School of Basic Sciences, Tarbiat Modares University, Tehran, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Cellular and Molecular Research Center, Research Institute on Cellular and Molecular Medicine, Urmia University of Medical Sciences, Urmia, Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz

Graphical Abstract:



Read Full-Text article